1. Lawrenz B., Jauckus J., Kupka M.S. et al. Fertility preservation in >1,000 patients: patient’s characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet 2010;283(3):651–6. DOI: 10.1007/s00404-010-1772-y
2. Belousov D.Yu., Cheberda A.E., Afanasyeva E.V., Gladkov O.A. Clinico-economic analysis of PD-1 inhibitors and combinations of BRAF and MEK inhibitors for the treatment of metastatic melanoma with a BRAF V600 gene mutation. Good clinical practice = Kachestvennaya klinicheskaya praktika 2018;2:13–28. (In Russ.) DOI: 10.24411/2588-0519-2018-10041
3. Zhukovets A.G. Current concepts and prospects for skin melanoma management. Onkologicheskij zhurnal: luchevaja diagnostika, luchevaja terapija = Journal of Oncology: Diagnostic Radiology and Radiotherapy 2015;9(4):69–76. (In Russ.).
4. Korman D.B. Evolution of drug therapy for melanoma. Voprosy onkologii = Oncology Issues 2017;63(3):358–67. (In Russ.). DOI: 10.37469/0507-3758-2017-63-3-358–67
5. Cancer Today. International Agency for Research on Cancer. Estimated number of deaths in 2020, World, both sexes, all ages. Available at: https://gco.iarc.fr/.